Detail Information of Post-Translational Modifications
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0394 Transporter Info | ||||
Gene Name | SLC52A2 | ||||
Transporter Name | Riboflavin transporter 3 | ||||
Gene ID | |||||
UniProt ID | |||||
Post-Translational Modification of This DT | |||||
Overview of SLC52A2 Modification Sites with Functional and Structural Information | |||||
Sequence |
MAAPTPARPV LTHLLVALFG MGSWAAVNGI WVELPVVVKE LPEGWSLPSY VSVLVALGNL
GLLVVTLWRR LAPGKDEQVP IRVVQVLGMV GTALLASLWH HVAPVAGQLH SVAFLALAFV LALACCASNV TFLPFLSHLP PRFLRSFFLG QGLSALLPCV LALVQGVGRL ECPPAPINGT PGPPLDFLER FPASTFFWAL TALLVASAAA FQGLLLLLPP PPSVPTGELG SGLQVGAPGA EEEVEESSPL QEPPSQAAGT TPGPDPKAYQ LLSARSACLL GLLAATNALT NGVLPAVQSF SCLPYGRLAY HLAVVLGSAA NPLACFLAMG VLCRSLAGLG GLSLLGVFCG GYLMALAVLS PCPPLVGTSA GVVLVVLSWV LCLGVFSYVK VAASSLLHGG GRPALLAAGV AIQVGSLLGA VAMFPPTSIY HVFHSRKDCA DPCDS |
||||
PTM type |
X-Phosphorylation
X: Amino Acid
|
Phosphorylation |
|||||
---|---|---|---|---|---|
Serine |
1 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Have the potential to influence SLC52A2 | [1] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Serine |
Modified Location |
273 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC52A2 Serine 273 has the potential to affect its expression or activity. | ||||
References | |||||
---|---|---|---|---|---|
1 | Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.